Posts in tag

biosimilars


Warning codes not always a block on biosimilar substitution, Pharmaceutical Benefits Scheme (PBS) says  Pharmacists receiving PBS warning reason codes 162 and 163 when substituting a biosimilar for a reference …

Pharmacy has a prominent role in the supply and provision of biosimilar medicines, and the profession has been slow to come to terms with this. Is the situation now changing? …

In the latest in our series based on 2017 UTS Pharmacy Barometer results, John Montgomery looks at how pharmacists view the riding tide of biosimilar medicines  There’s little doubt biosimilar …

The ACTU has attacked the government over the revived TPP, claiming it would drive up drug prices ACTU president Ged Kearney says that the Trans Pacific Partnership, which is set …

A higher than usual degree of pharmacovigilance is required when patients are switched to new biosimilar medications, say Australian experts Writing in the latest Australian Prescriber two pharmacy academics have stressed …